3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Urinary Bladder Neoplasms
3
Sarcoma
1
Pathologic Complete Response
1
Neoplasms
1
Interventions
Trastuzumab
2
toripalimab
1
pyrotinib
1
Vinblastine
1
Transurethral Resection of Bladder
1
Thalidomide
1
TP protocol
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neoadjuvant Therapy
1
Metformin
1
Magnetic Resonance Imaging
1
Immunohistochemistry
1
Esophagectomy
1
Endoscopy
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Diffusion Magnetic Resonance Imaging
1
Dexamethasone
1
Decitabine
1
Cytarabine
1
Cisplatin
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Carboplatin
1
Bortezomib
1
Blood Specimen Collection
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pathologic Complete Response
×
Transurethral Resection of Bladder
×
Clear all
NCT05684874
2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA
Unknown
25 enrolled